v3.26.1
Acquisition of Azora and Pipe Issuance - (Details) - USD ($)
 3 Months Ended 6 Months Ended
Aug. 11, 2026
Jun. 11, 2026
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Acquisition of Azora and Pipe Issuance [Line Items]            
Consideration transferred         $ 41,503,000  
Loss on extinguishment     $ (6,054,000) (6,054,000)
Newly issued shares         5,600,000  
Azora Therapeutics, LLC [Member]            
Acquisition of Azora and Pipe Issuance [Line Items]            
Consideration transferred         $ 41,500,000  
Percentage of acquisition owned     51.00%   51.00%  
Warrant [Member]            
Acquisition of Azora and Pipe Issuance [Line Items]            
Exercise price per share     $ 2.7489   $ 2.7489  
Initial Closing Pre-Funded Warrant [Member] | Warrant [Member]            
Acquisition of Azora and Pipe Issuance [Line Items]            
Aggregate purchase price         $ 26,800  
Adial’s Pipeline [Member]            
Acquisition of Azora and Pipe Issuance [Line Items]            
Percentage of merger owned     7.70%   7.70%  
Adial’s Pipeline [Member] | Pre-Funded Warrants [Member]            
Acquisition of Azora and Pipe Issuance [Line Items]            
Exercise price per share $ 2.7489          
Aggregate shares 2,031,603          
Loss on extinguishment $ 6,100,000          
Securities Purchase Agreement [Member]            
Acquisition of Azora and Pipe Issuance [Line Items]            
Principal amount         $ 5,500,000  
Securities Purchase Agreement [Member] | Warrant [Member]            
Acquisition of Azora and Pipe Issuance [Line Items]            
Exercise price per share     $ 2.7489   $ 2.7489  
Aggregate shares   9,749,345        
Aggregate purchase price         $ 26,800  
Exchange Agreements [Member] | Pre-Funded Warrants [Member]            
Acquisition of Azora and Pipe Issuance [Line Items]            
Shares issued   2,031,603        
Exercise price per share     $ 2.7489   $ 2.7489  
Aggregate shares   2,031,603        
Preferred Stock [Member]            
Acquisition of Azora and Pipe Issuance [Line Items]            
Preferred shares issued     12,930.617   12,930.617  
Common Stock [Member]            
Acquisition of Azora and Pipe Issuance [Line Items]            
Shares issued         437,421  
Combined price   $ 2.7489        
Common Stock [Member] | Azora Therapeutics, LLC [Member]            
Acquisition of Azora and Pipe Issuance [Line Items]            
Percentage of acquisition owned     41.30%   41.30%  
Common Stock [Member] | Warrant [Member]            
Acquisition of Azora and Pipe Issuance [Line Items]            
Aggregate shares   9,749,345        
Common Stock [Member] | Pre-Funded Warrants [Member]            
Acquisition of Azora and Pipe Issuance [Line Items]            
Aggregate shares   2,031,603        
Common Stock [Member] | Initial Closing Pre-Funded Warrant [Member]            
Acquisition of Azora and Pipe Issuance [Line Items]            
Shares issued   9,749,345        
Price per share   $ 2.7489        
Series A Preferred Stock [Member]            
Acquisition of Azora and Pipe Issuance [Line Items]            
Convertible preferred stock     1,000   1,000  
Conversion of common stock         1,000  
Convertible Common Stock [Member]            
Acquisition of Azora and Pipe Issuance [Line Items]            
Conversion of common stock         1,177,782